Jennifer Baldock has sold SGRY and made no open-market buys since Aug 2016

Jennifer Baldock is an Executive Vice President and Chief Administrative & Development Officer at Surgery Partners, Inc., a role she has held since February 2019.( Previously, she served as EVP and General Counsel following Surgery Partners' acquisition of Symbion in 2014, and prior to that as General Counsel and Chief Compliance Officer.( Her earlier career includes positions as Assistant General Counsel for Ambulatory Services of America and Renal Care Group, as well as practicing law at Waller Lansden Dortch & Davis.( Based in Nashville, TN, she holds a Bachelor of Arts in Accounting and Economics and a J.D. in Law.(

Baldock has been active as a corporate insider, recently reporting equity transactions including the receipt of 106,307 restricted stock awards on March 5, 2026, at $14.11 per share, and the sale of 10,082 shares on March 6, 2026, at $13.70 to cover tax withholding obligations, leaving her with direct ownership of 332,272 shares.( She contributes to strategic initiatives, such as ASC-hospital partnerships and health system collaborations.(

Written by Perplexity from public sources.